IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

$68.49
-1.04 (-1.50%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -67.2% upside
Low Target $15.33
Average Target $22.47
High Target $35.88
Current Price $68.49
Current
$68.49
Target
$22.47
$15.33 $22.47 avg $35.88
Scenario Analysis
Bear Case
$15.33
-77.6%
Low target
Base Case
$22.47
-67.2%
Avg target
Bull Case
$35.88
+-47.6%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$99.50
-31.2% from high
52-Week Low
$40.00
+71.2% from low
50-Day SMA
$78.91
-13.2% vs SMA
200-Day SMA
$68.08
+0.6% vs SMA
RSI (14)
34.9
Neutral
Target vs 52W High
$22.47
-77.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%